Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!

被引:10
|
作者
Santoro, Rita Carlotta [1 ]
Molinari, Angelo Claudio [2 ]
Leotta, Marzia [1 ]
Martini, Tiziano [3 ]
机构
[1] Azienda Osped Pugliese Ciaccio, Hemostasis & Thrombosis Unit, I-88100 Catanzaro, Italy
[2] IRCCS Ist Giannina Gaslini, Thrombosis & Hemostasis Unit, I-16147 Genoa, Italy
[3] Cesena Gen Hosp, Ctr Congenital Bleeding Disorders, Immunohaematol & Transfus Med, I-47521 Cesena, Italy
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 06期
关键词
activated partial thromboplastin time (aPTT); coagulation factor defect; mixing test; intrinsic pathway; circulating anticoagulants; bleeding patient; LABORATORY IDENTIFICATION; CLINICAL-SIGNIFICANCE; LUPUS ANTICOAGULANT; FACTOR INHIBITORS; COAGULATION; HEMOPHILIA; MANAGEMENT; ANTIBODIES; DIAGNOSIS; HEMOLYSIS;
D O I
10.3390/medicina59061169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice. How the detection of prolonged activated aPTT with a normal prothrombin time is interpreted is therefore very important. In daily practice, the detection of this abnormality often leads to delayed surgery and emotional stress for patients and their families and may be associated with increased costs due to re-testing and coagulation factor assessment. An isolated, prolonged aPTT is seen in (a) patients with congenital or acquired deficiencies of specific coagulation factors, (b) patients receiving treatment with anticoagulants, mainly heparin, and (c) individuals/patients with circulating anticoagulants. We summarize here what may cause an isolated prolonged aPTT and evaluate the preanalytical interferences. The identification of the cause of an isolated prolonged aPTT is of the utmost importance in ensuring the correct diagnostic workup and therapeutic choices.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review
    Rasmussen, Katrine Laura
    Philips, Malou
    Tripodi, Armando
    Goetze, Jens Peter
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (06) : 519 - 525
  • [2] What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?
    Falay, Mesude
    Senes, Mehmet
    Yucel, Dogan
    Turhan, Turan
    Dagdas, Simten
    Pekin, Melike
    Nazaroglu, Namik K.
    Ozet, Gulsum
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (06)
  • [3] An Evaluation of the Activated Partial Thromboplastin Time Waveform
    Matsumoto, Takeshi
    Wada, Hideo
    Fujimoto, Naoki
    Toyoda, Junki
    Abe, Yasunori
    Ohishi, Kohshi
    Yamashita, Yoshiki
    Ikejiri, Makoto
    Hasegawa, Kei
    Suzuki, Kei
    Imai, Hiroshi
    Nakatani, Kaname
    Katayama, Naoyuki
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (05) : 764 - 770
  • [4] Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease
    Raffini, Leslie J.
    Niebanck, Alison E.
    Hrusovsky, Joanne
    Stevens, Amanda
    Blackwood-Chirchir, Anne
    Ohene-Frempong, Kwaku
    Kwiatkowski, Janet L.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (05) : 589 - 593
  • [5] Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
    Spencer A.
    Pearce M.I.
    Ames P.R.J.
    Thrombosis Journal, 9 (1)
  • [6] Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent
    Kaneko, Yousuke
    Sugasaki, Motoki
    Okada, Naoto
    Niimi, Mako
    Yasui, Saya
    Hori, Taiki
    Aihara, Ken-ichi
    Takishita, Makoto
    Abe, Masahiro
    Nakamura, Shingen
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (02) : E72 - E75
  • [7] Implications of deranged activated partial thromboplastin time for anaesthesia and surgery
    Loizou, E.
    Mayhew, D. J.
    Martlew, V.
    Murthy, B. V. S.
    ANAESTHESIA, 2018, 73 (12) : 1557 - 1563
  • [8] Activated partial thromboplastin time and risk of future venous thromboembolism
    Zakai, Neil A.
    Ohira, Tetsuya
    White, Richard
    Folsom, Aaron R.
    Cushman, Mary
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (03): : 231 - 238
  • [9] An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform
    Katayama, Haruna
    Matsumoto, Takeshi
    Wada, Hideo
    Fujimoto, Naoki
    Toyoda, Junki
    Abe, Yasunori
    Ohishi, Kohshi
    Yamashita, Yoshiki
    Ikejiri, Makoto
    Habe, Koji
    Katayama, Naoyuki
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (07) : 1170 - 1176
  • [10] An international study on activated partial thromboplastin time prolongation. Part 2: Interpretative commenting
    Miquel Bauca, Josep
    Ajzner, Eva
    Cadamuro, Janne
    Hillarp, Andreas
    Kristoffersen, Ann Helen
    Meijer, Piet
    CLINICA CHIMICA ACTA, 2022, 535 : 174 - 179